ScoreWhy is Guizhou Xinbang Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -0.84% and Operating profit at -7.54% over the last 5 years
2
Flat results in Mar 25
- NET PROFIT(HY) At CNY -33.96 MM has Grown at -134.14%
- ROCE(HY) Lowest at 1.23%
- INTEREST(Q) At CNY 5.79 MM has Grown at 16.49%
3
With ROE of 2.17%, it has a fair valuation with a 0.93 Price to Book Value
- Over the past year, while the stock has generated a return of 5.35%, its profits have fallen by -53.2%
- At the current price, the company has a high dividend yield of 1.8
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Guizhou Xinbang Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Guizhou Xinbang Pharmaceutical Co., Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Guizhou Xinbang Pharmaceutical Co., Ltd.
-1.25%
0.29
39.04%
China Shanghai Composite
14.77%
1.01
15.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-0.84%
EBIT Growth (5y)
-7.54%
EBIT to Interest (avg)
7.85
Debt to EBITDA (avg)
1.08
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.79
Tax Ratio
17.45%
Dividend Payout Ratio
112.15%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.50%
ROE (avg)
4.68%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
43
Industry P/E
Price to Book Value
0.93
EV to EBIT
24.10
EV to EBITDA
12.86
EV to Capital Employed
0.93
EV to Sales
1.06
PEG Ratio
NA
Dividend Yield
1.85%
ROCE (Latest)
3.87%
ROE (Latest)
2.17%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -2.73% (YoY
NET PROFIT(Q)
At CNY 41.24 MM has Grown at 62.73%
-16What is not working for the Company
NET PROFIT(HY)
At CNY -33.96 MM has Grown at -134.14%
ROCE(HY)
Lowest at 1.23%
INTEREST(Q)
At CNY 5.79 MM has Grown at 16.49%
INVENTORY TURNOVER RATIO(HY)
Lowest at 5.05%
NET SALES(Q)
Lowest at CNY 1,434.35 MM
Here's what is working for Guizhou Xinbang Pharmaceutical Co., Ltd.
Net Profit
At CNY 41.24 MM has Grown at 62.73%
over average net sales of the previous four periods of CNY 25.35 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Raw Material Cost
Fallen by -2.73% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Guizhou Xinbang Pharmaceutical Co., Ltd.
Interest
At CNY 5.79 MM has Grown at 16.49%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
Lowest at CNY 1,434.35 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Inventory Turnover Ratio
Lowest at 5.05%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
